Ignite Creation Date:
2024-05-06 @ 9:35 AM
Last Modification Date:
2024-10-26 @ 12:17 PM
Study NCT ID:
NCT03026218
Status:
COMPLETED
Last Update Posted:
2022-03-22
First Post:
2017-01-11
Brief Title:
Group and Mobile Care for Gestational Diabetes
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Study Overview
Official Title:
Group and Mobile Care for Gestational Diabetes
Status:
COMPLETED
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A critical variation in the provision of prenatal care to women with GDM is the need to keep patients engaged with their care between visits by tracking glucose levels using finger sticks and making dietary and other lifestyle modifications to keep these levels at or close to normal Multiple studies have demonstrated that the use of mobile devices can improve medical outcomes In order to keep patients engaged between appointments and improve self-carelifestyle we will study the use of a glucose monitoring system with nutrition therapy called GlucoseMamaGM GM is a mobile app on the iOS system that individuals with GDM will use to tract blood sugars and number of carbs consumed In addition it will give the user positive feedback and rewards for using the system This model of group care with mobile phone monitoring and reminders for women with GDM has not been previously studied A randomized control trial is purposed to determine if this approach improves patient care The investigators hypothesize that group prenatal care along with inter-session mobile therapy will increase dietary compliance and therefore reduce the number of individuals requiring pharmacologic therapy and improve neonatal outcomes during pregnancy Group prenatal care GPC will provide a community foundation to improve learning and increase the motivation of patients to learn and change This motivation will be further strengthened by the use of the GlucoseMama monitoring system which will provide each patient with glucose tracking and individualized nutritional support
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None